Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1). 1990

J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
Research Division, Roche Products Limited, Welwyn Garden City, Hertfordshire, England.

A range of 2'-fluoro and 2',3'-difluoro analogues of pyrimidine deoxyribonucleosides have been synthesized and evaluated against human immunodeficiency virus (HIV-1) in a human lymphoblastoid cell line. Among these compounds, 1-(2,3-dideoxy-2-fluoro-beta-D-threopentofuranosyl)cytosine (12), 2',3'-didehydro-2',3'-dideoxy-2'-fluorocytidine (35), 1-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)cytosine (41), and 3'-deoxy-2',3'-didehydro-2'-fluorothymidine (45) were found to have significant antiviral activity, with IC50 values of 0.65, 10, 10, and 100 microM, respectively. The structure-activity relationships are discussed.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003853 Deoxyribonucleosides A purine or pyrimidine base bonded to DEOXYRIBOSE.
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
February 1988, Journal of medicinal chemistry,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
December 1988, Gene,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
March 2005, Journal of medicinal chemistry,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
January 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
March 2001, Bioscience, biotechnology, and biochemistry,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
January 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
February 1987, Journal of medicinal chemistry,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
October 2015, Virology,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
June 1991, Chemical & pharmaceutical bulletin,
J A Martin, and D J Bushnell, and I B Duncan, and S J Dunsdon, and M J Hall, and P J Machin, and J H Merrett, and K E Parkes, and N A Roberts, and G J Thomas
December 1994, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!